Skip to main content
Back to Antler

Antler's Pharmaceutical Portfolio

Browse 4 Pharmaceutical companies funded by Antler. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
4
Total Funding in Pharmaceutical
$10.2M

Pharmaceutical Portfolio Companies (4)

Export
Advanced MaterialsBiometricsBiopharmaBiotechnologyEducationHealth CareLife ScienceManufacturingMedicalPharmaceutical

Cellivate Technologies develops engineered cell culture surfaces, consumables, and services for adherent cell growth and scale-up.

Singapore, Singapore
August 2024
$1.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)B2BGenerative AIHealth CareMachine LearningMarketplaceMedicalNatural Language ProcessingPharmaceutical

GenAI-powered Global B2B Healthcare Marketplace

London, United Kingdom
June 2022
$7.9M
Series A

Founder Contacts

30,000+ verified contacts

E-CommercePharmaceutical

Largest B2B Pharma Marketplace (Global)

Singapore, Singapore
October 2024
$1.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Clinical TrialsData ManagementPharmaceuticalSoftware

Kenosha AI is a developer of an artificial intelligence platform designed for the clinical research industry.

San Francisco, United States
March 2024
$250K
Pre-Seed

Founder Contacts

30,000+ verified contacts

Explore Antler's Full Portfolio

View all companies funded by Antler across every industry and funding stage.

View Full Antler Portfolio